Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Intermedical Care and Lab Hospital Public Company Limited (IMH.BK)
Bangkok, TH
Intermedical Care and Lab Hospital Public Company Limited manages a chain of private medical facilities. The company delivers a broad spectrum of occupational health solutions, featuring yearly physical examinations, health risk evaluations, and pre-employment screenings. They also conduct health assessments for international workers, provide outpatient medical care, immunization services, and offer training in first aid and cardiopulmonary resuscitation. Additionally, the firm specializes in environmental monitoring, encompassing workplace health and safety oversight, ventilation air quality assessment, general atmospheric analysis, and water quality testing. This includes thorough monitoring, sample collection, and analytical services in accordance with environmental impact assessment guidelines. The organization was established in 1996 and is based in Bangkok, Thailand.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.68% | -3.29% | -2.65% | -2.00% | -17.88% | -3.92% | -26.50% | -71.73% | -47.03% | -37.71% | -37.71% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%-2.1% Q1'26: +2.3% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%-137.1% Q1'26: +216.3% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+16.9% ★ Q1'26: +7.6% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%-17.9% Q1'26: +21.4% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%-8.1% Q1'26: +8.7% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+6.2% Q1'26: +10.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×-13.70× Q1'26: 4.33× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
|---|---|---|---|---|---|
| Revenue |
942.64M
est: 937.00M (+0.6%)
|
639.83M
est: 768.00M (-16.7%)
|
669.61M
est: 773.44M (-13.4%)
|
771.07M
est: 1.11B (-30.7%)
|
754.92M
est: 1.06B (-28.6%)
|
| EBITDA |
568.07M
est: 235.05M (+141.7%)
|
257.82M
est: 192.66M (+33.8%)
|
113.31M
est: 171.51M (-33.9%)
|
29.74M
est: 246.58M (-87.9%)
|
-78.98M
est: 234.61M (-133.7%)
|
| EBIT |
531.56M
est: 172.95M (+207.3%)
|
222.05M
est: 141.76M (+56.6%)
|
70.97M
est: 125.44M (-43.4%)
|
-21.19M
est: 180.34M (-111.7%)
|
-134.80M
est: 171.59M (-178.6%)
|
| Net Income |
422.70M
est: 428.72M (-1.4%)
|
173.11M
est: 269.64M (-35.8%)
|
21.48M
est: -37.98M (+156.6%)
|
-74.46M
est: 275.03M (-127.1%)
|
-188.69M
est: 256.85M (-173.5%)
|
| SGA |
103.96M
est: 203.67M (-49.0%)
|
124.31M
est: 166.93M (-25.5%)
|
178.75M
est: 165.67M (+7.9%)
|
143.62M
est: 238.19M (-39.7%)
|
236.45M
est: 226.62M (+4.3%)
|
| EPS |
1.97
est: 2.00 (-1.7%)
|
0.81
est: 1.26 (-35.7%)
|
0.10
est: -0.17 (+159.9%)
|
-0.35
est: 1.21 (-128.9%)
|
-0.83
est: 1.13 (-173.5%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-19 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-18 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-15 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-14 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-13 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-12 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Thibdee Mangkalee | Executive Director | 300.0K | male |
| Poramaporn Pavarojkit | Deputy Chief Executive Officer, President of General Operation & Director | — | female |
| Ratchaneeporn Mokkarawut | Executive Director, Chief Financial Officer & Acting Account Manager | — | female |
| Narongphon Howcharoen | President of Medical & Nursing | — | — |
| Sittiwat Kamkatwong | Chief Executive Officer & Director | — | — |
| Suntharee Noinart | President of Marketing | — | female |
| Siriluck Rahong | Company Secretary | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for IMH.BK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
